PYRAZOLDERIVATE

Patent europeic · EP3400220 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3400220
Numer da la dumonda
EP16882855
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
05-01-2016
Publitgà
14-11-2018
Concedì
24-03-2021
Stritgà
24-08-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 401/06 (2006.01)
C07D 205/04 (2006.01)
C07D 207/10 (2006.01)
A61K 31/397 (2006.01)
A61P 25/00 (2006.01)
A61P 29/00 (2006.01)
Dumonda PCT
PCT/CN2016/070115 05.01.2016
Publicaziun PCT
WO2017/117708 13.07.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-08-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 24.08.2022

  2. 09-02-2022

    Midada

    Published in Swissreg on 09.02.2022

  3. 24-03-2021

    Concedì

    Published in Swissreg on 24.03.2021

Partidas

Possessur

Hua Medicine (Shanghai) Ltd.

275 Ai Di Sheng Road, Pudong, Shanghai 201203, CN

Inventur

CHEN, Li

Shanghai 201203, CN

JIN, Xiaowei

Shanghai 201203, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.